通过对母胎生理学基础的药物动力学建模预测胎儿布普伦诺芬暴露
Matthijs W van Hoogdalem1,2, Ryota Tanaka1, Khaled Abduljalil3
1Division of Translational and Clinical Pharmacology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229, USA.
Pharmaceutics
|March 28, 2024
概括
这项研究开发了一种母胎药理动力学模型,以预测胎儿对布普伦诺芬的暴露. 这种模型可以帮助量身定制剂量,以减少新生儿阿片类药物戒断综合征 (NOWS) 的严重程度.
科学领域:
- 药理学 药理学是指药理学的学科.
- 药理动力学 药理动力学
- 产妇胎儿医学 产妇胎儿医学
背景情况:
- 布普伦诺芬穿过胎盘,可能会增加新生儿阿片类药物戒断综合征 (NOWS) 的严重程度,并增加产前暴露.
- 优化布普伦诺芬剂量需要了解胎儿暴露水平,并预测NOWS的严重程度.
研究的目的:
- 开发一种基于母胎生理学上的药理动力学 (PBPK) 模型,用于语言下布普伦诺芬.
- 预测胎儿布普伦诺芬暴露及其与NOWS严重程度的相关性.
主要方法:
- 使用Simcyp (v21.0) 创建了一个母胎PBPK模型,以模拟布普伦诺芬的胎盘穿越.
- 该模型纳入了孕期引起的母亲代谢和跨粘膜吸收的变化.
- 模型预测与母亲的药理动力学数据和带血度进行了验证.
主要成果:
- 孕产妇的布普伦诺芬药理动力学在第二和第三个三个月以及产后都得到了准确的预测.
- 预测的带血度与观察值 (几何平均比1.15) 非常接近,误差为95.2%.
- 该模型充分预测了母体和胎儿两部分的布普伦诺芬度.
结论:
- 开发的母胎PBPK模型准确预测胎儿布普伦诺芬暴露.
- 这个工具可以为个性化的布普伦诺芬剂量策略提供信息,以减轻NOWS.
- 需要进一步调查预测胎儿暴露和NOWS严重程度之间的相关性.
更多相关视频
相关概念视频
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
38
Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion,...
A recent model describes pravastatin's hepatobiliary excretion,...
38
Pharmacokinetic Models: Comparison and Selection Criterion
70
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
70
Pharmacokinetic Models: Overview
672
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
672
Physiological Pharmacokinetic Models: Assumption with Protein Binding
43
Physiological models with protein binding in pharmacokinetics offer a sophisticated approach to understanding drug disposition. These models consider drug-protein interactions, enabling them to effectively predict drug concentrations in different organs and tissues. This precision aids in accurate drug dosing, providing a significant advantage over conventional models. A key process within these models is equilibration, which ensures that drug concentrations achieve a steady state within the...
43
Analysis of Population Pharmacokinetic Data
254
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
254
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
69
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
69


